直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Sanctions Imposed Against Litigant for “Abusive” Litigation Conduct

March 5, 2021

Authored and Edited by R. Gordon Wright; Kara A. Specht; Elizabeth D. Ferrill

In Arunachalam v. International Business Machines Corp., the Federal Circuit affirmed the district court’s order imposing sanctions against plaintiff and patent owner, Dr. Arunachalam.

Dr. Arunachalam sued IBM, SAP, and JPMorgan Chase (Appellees) for alleged patent infringement and violations of racketeering laws. The district court dismissed the racketeering claims, explaining that patent infringement does not qualify as a criminal act. Meanwhile, the Patent Trial and Appeal Board found the asserted claims of ’506 patent unpatentable. The district court then dismissed Dr. Arunachalam’s infringement claim and imposed monetary sanctions against Dr. Arunachalam for pursuing “a baseless racketeering lawsuit.” Slip op. at 10.

The Federal Circuit held the sanctions against Dr. Arunachalam were warranted because the Appellees expended resources “responding to Dr. Arunachalam’s vexatious and wanton litigation conduct.” Id. at 14. Supporting the decision, the Court cited a laundry list of Dr. Arunachalam’s frivolous conduct, including filing seven motions to recuse the judge and claiming the Appellees colluded with the judge to evade U.S. laws. The Court also used its inherent power to impose additional sanctions against Dr. Arunachalam by striking “scandalous and irrelevant statements” made in her appeal brief. The stricken statements included that the Court “committed treason” and the district court judges “must be arrested.” Id. at 19.

Tags

Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC), attorney fees, permanent injunctions

For more information

  • Lakshmi Arunachalam v. International Business Machines Corporation

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

Related Offices

Atlanta, GA

Washington, DC

Contacts

R. Gordon Wright
Associate
Atlanta, GA
+1 404 653 6555
Email
Kara A. Specht
Partner
Atlanta, GA
+1 404 653 6481
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP